Pfizers Covid-19 Vaccine: FDA to Begin Review and Everything You Need to Know – The Wall Street Journal

Pfizer Inc. and partner BioNTech SE said they would ask the U.S. Food and Drug Administration on Friday to clear the companies Covid-19 vaccine. If the agency gives a thumbs-up, the shot would be the first to go into use in the U.S. Heres what we know and dont know.

Unclear, though the agency is expected to move quickly given the urgent need for a vaccine. It could take two or three weeks. The FDA must review data from the 44,000-subject trial on the vaccines safety and effectiveness....

Read the original here:

Pfizers Covid-19 Vaccine: FDA to Begin Review and Everything You Need to Know - The Wall Street Journal

Related Posts
Tags: